Table 3.
The differences of clinical features between ICS, OCS and GCS group
| ICS(n=123) | OCS(n=48) | GCS(n=60) | P value* | |
|---|---|---|---|---|
| Age (years) | 48(16–83) | 58.5(26–76) | 59.5(20–76)* | 0.0173 |
| Asthma duration (years) | 1.5(0.1–40) | 2.5(0.1–20) | 5.0(0.1–50)* | 0.0009 |
| Plasma IL-8 (pg/ml) | 61(5–1957) | 186(7.52–7500) | 235(5–7227) | 0.0001 |
| Plasma TNF-a (pg/ml) | 6.005(2.6–11.1) | 6.6(4–16.2) | 6.28(4–18.4) | ns |
| Plasma IL-6 (pg/ml) | 2.52(2–9.85) | 2.92(2–12.8) | 3.2(2–44.71)* | 0.045 |
| FENO (ppb) | 17(5–174) | 23(5–162) | 30(5–145)* | 0.0237 |
| Serum SOD (U/ml) | 165(130–239) | 154(122–243) | 147(87–179)* | 0.0054 |
*:
Compared with ICS group